Search results
Cigna Medicare Advantage Plans 2024 Review - NerdWallet
Nerdwallet· 2 days agoStar ratings are determined by the Centers for Medicare & Medicaid Services (CMS). Cigna plans are...
Story from SummaCare: The right Medicare Advantage plan will answer many common questions
Akron Beacon Journal· 4 days agoThe doctor-patient relationship is one of life’s most important interactions. A patient should...
Navigating the Complexities of FEHB & Medicare in Retirement
TheStreet.com· 3 days agoUnlock the secrets of retirement healthcare with Jae Oh's expert tips on navigating FEHB and Medicare complexities.
CMS Issues Draft Guidance on Inflation Reduction Act (IRA) Drug Price Negotiation Program for 2027 |...
JD Supra· 6 days agoCMS is seeking comment on this draft guidance for the drug price negotiation process for IPAY 2027, for which the next 15 Part D drugs will be selected by February 1...and ...
Q1 2024 Supernus Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoIn addition, we plan to initiate a Phase one single dose study of SPM...four three in healthy adults following submission of an investigational new drug ...
Better Health Care Newsletter - May 2024 | JD Supra
JD Supra· 6 days agoFederal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big...
Bactrim Cost 2024: Coupons and More
Healthline· 6 days agoBactrim (sulfamethoxazole/trimethoprim) is a prescription drug used to prevent and treat various infections. Bactrim’s cost may depend on factors such as your dosage, whether ...
Earnings call: Intra-Cellular reports robust growth in CAPLYTA sales By Investing.com
Investing.com· 5 days agoIntra-Cellular Therapies (NASDAQ: NASDAQ:ITCI) has announced a significant increase in revenues for...
Earnings call: Assertio Holdings reports growth and CEO search progress
Investing.com· 6 days agoAssertio Holdings (ASRT) has provided a detailed overview of their first-quarter financial...
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
FOX 23 News Albany· 4 days agoXPOVIO® (selinexor) Net Product Revenue of $26.0 Million – – Reaffirms Full Year 2024 Total ...
